Sort
15,842 grants matching “pancreatic cancer”
Precision Management of Cystic Precursors to Pancreatic Cancer
$477,775Pari Vijay Pandharipande · Massachusetts General Hospital · R01 · FY2019 · CA
Targeting stem-like cells and their niche in pancreatic cancer
$477,667Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA
Pulsed Focused Ultrasound (pFUS) exposures and devices for tissue permeabilization without contrast agents
$477,497Tatiana Khokhlova · University Of Washington · R01 · FY2017 · EB
Histone chaperones and cell state regulation
$477,419Amanda Rietta Wasylishen · University Of Cincinnati · R01 · FY2024 · DK
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$477,379Dai Fukumura · Massachusetts General Hospital · R01 · FY2020 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$477,379Dai Fukumura · Massachusetts General Hospital · R01 · FY2018 · CA
Physiologic mechanisms of ion channel regulation
$477,370Anne E Carlson · University Of Pittsburgh At Pittsburgh · R35 · FY2024 · GM
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$477,283Douglas Robert Spitz · University Of Iowa · P01 · FY2021 · CA
Project 2: Exploiting Labile Iron Pools for Improving NSCLC Therapy Using Pharmacological Ascorbate
$477,283Douglas Robert Spitz · University Of Iowa · P01 · FY2020 · CA
Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer
$477,278Or P. Gozani · Stanford University · R01 · FY2021 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$477,129James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
The Complement System and Cancer Cachexia
$477,124Andrew Robert Judge · University Of Florida · R01 · FY2022 · AR
The Complement System and Cancer Cachexia
$477,124Andrew Robert Judge · University Of Florida · R01 · FY2023 · AR
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$477,000Santhi Swaroop Vege · Mayo Clinic Rochester · U01 · FY2023 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$477,000Santhi Swaroop Vege · Mayo Clinic Rochester · U01 · FY2021 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$477,000Santhi Swaroop Vege · Mayo Clinic Rochester · U01 · FY2022 · DK
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$477,000Santhi Swaroop Vege · Mayo Clinic Rochester · U01 · FY2020 · DK
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$476,998Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center
$476,995Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · DK
Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer: Pittsburgh Clinical Center
$476,995Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · DK
Highly Sensitive Detection of Occult Pancreatic Cancer Using Intraoperative Molecular Imaging
$476,970George Poultsides · Stanford University · R01 · FY2025 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$476,752Wei R. Chen · University Of Oklahoma · R01 · FY2023 · CA
UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer
$476,683Andre Elias Nel · University Of California Los Angeles · U01 · FY2017 · CA
Highly Sensitive Detection of Occult Pancreatic Cancer Using Intraoperative Molecular Imaging
$476,498George Poultsides · Stanford University · R01 · FY2023 · CA
VEGF and PDGF in angiogenesis and tumor progression
$476,313David A Cheresh · University Of California, San Diego · R37 · FY2010 · CA